Daniela Matei
Affiliations: | Biochemistry and Molecular Biology | Indiana University, Bloomington, Bloomington, IN, United States |
Area:
Molecular Biology, OncologyGoogle:
"Daniela Matei"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Valdivia A, Cowan M, Cardenas H, et al. (2024) E2F1 mediates competition, proliferation and response to cisplatin in cohabitating resistant and sensitive ovarian cancer cells. Frontiers in Oncology. 14: 1304691 |
| Wang Y, Situ X, Cardenas H, et al. (2024) Preclinical evaluation of NTX-301, a Novel DNA Hypomethylating Agent in Ovarian Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Wang Y, Duval AJ, Adli M, et al. (2024) Biology-driven therapy advances in high-grade serous ovarian cancer. The Journal of Clinical Investigation. 134 |
| Valdivia A, Vagadia PP, Guo G, et al. (2023) Discovery and Characterization of PROTACs Targeting Tissue Transglutaminase (TG2). Journal of Medicinal Chemistry. 66: 9445-9465 |
| Zhang Y, Wang Y, Zhao G, et al. (2023) Metabolic dependencies and targets in ovarian cancer. Pharmacology & Therapeutics. 245: 108413 |
| Barber EL, Chen S, Pineda MJ, et al. (2022) Clinical and Biological Activity of Chemoimmunotherapy in Advanced Endometrial Adenocarcinoma: A Phase II Trial of the Big Ten Cancer Research Consortium. Cancer Research Communications. 2: 1293-1303 |
| Zhang Y, Wang Y, Valdivia A, et al. (2022) DOT1L Regulates Ovarian Cancer Stem Cells by Activating β-catenin Signaling. Molecular Cancer Research : McR |
| Armstrong DK, Alvarez RD, Backes FJ, et al. (2022) NCCN Guidelines® Insights: Ovarian Cancer, Version 3.2022. Journal of the National Comprehensive Cancer Network : Jnccn. 20: 972-980 |
| Condello S, Prasad M, Atwani R, et al. (2022) Tissue transglutaminase activates integrin-linked kinase and β-catenin in ovarian cancer. The Journal of Biological Chemistry. 102242 |
| Chen S, Xie P, Cowan M, et al. (2022) Epigenetic priming enhances anti-tumor immunity in platinum resistant ovarian cancer. The Journal of Clinical Investigation |